Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study

被引:0
|
作者
Ronald E. Myers
Amy E. Leader
Jean Hoffman Censits
Edouard J. Trabulsi
Scott W. Keith
Anett M. Petrich
Anna M. Quinn
Robert B. Den
Mark D. Hurwitz
Costas D. Lallas
Sarah E. Hegarty
Adam P. Dicker
Charnita M. Zeigler-Johnson
Veda N. Giri
Hasan Ayaz
Leonard G. Gomella
机构
[1] Sidney Kimmel Medical College,Division of Population Science, Department of Medical Oncology
[2] Thomas Jefferson University,Department of Urology
[3] Sidney Kimmel Medical College,Department of Pharmacology and Experimental Therapeutics
[4] Thomas Jefferson University,Department of Radiation Oncology
[5] Sidney Kimmel Medical College,School of Biomedical Engineering, Science and Health Systems
[6] Thomas Jefferson University,undefined
[7] Sidney Kimmel Medical College,undefined
[8] Thomas Jefferson University,undefined
[9] Drexel University,undefined
来源
Journal of Cancer Education | 2018年 / 33卷
关键词
Prostate cancer; Active surveillance; Shared decision making; Decision support interventions;
D O I
暂无
中图分类号
学科分类号
摘要
This study aimed to explore the effects of a decision support intervention (DSI) and shared decision making (SDM) on knowledge, perceptions about treatment, and treatment choice among men diagnosed with localized low-risk prostate cancer (PCa). At a multidisciplinary clinic visit, 30 consenting men with localized low-risk PCa completed a baseline survey, had a nurse-mediated online DS session to clarify preference for active surveillance (AS) or active treatment (AT), and met with clinicians for SDM. Participants also completed a follow-up survey at 30 days. We assessed change in treatment knowledge, decisional conflict, and perceptions and identified predictors of AS. At follow-up, participants exhibited increased knowledge (p < 0.001), decreased decisional conflict (p < 0.001), and more favorable perceptions of AS (p = 0.001). Furthermore, 25 of the 30 participants (83 %) initiated AS. Increased family and clinician support predicted this choice (p < 0.001). DSI/SDM prepared patients to make an informed decision. Perceived support of the decision facilitated patient choice of AS.
引用
收藏
页码:180 / 185
页数:5
相关论文
共 50 条
  • [21] Contemporary Use of Initial Active Surveillance Among Men in Michigan with Low-risk Prostate Cancer
    Womble, Paul R.
    Montie, James E.
    Ye, Zaojun
    Linsell, Susan M.
    Lane, Brian R.
    Miller, David C.
    EUROPEAN UROLOGY, 2015, 67 (01) : 44 - 50
  • [22] Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer
    Papadopoulos, Efthymios
    Alibhai, Shabbir M. H.
    Tomlinson, George A.
    Matthew, Andrew G.
    Nesbitt, Michael
    Finelli, Antonio
    Trachtenberg, John
    Santa Mina, Daniel
    CANCER CAUSES & CONTROL, 2019, 30 (09) : 1009 - 1012
  • [23] Facilitating Shared Decision Making About Prostate Cancer Screening Among African American Men
    Sandiford, Lynette
    D'Errico, Ellen M.
    ONCOLOGY NURSING FORUM, 2016, 43 (01) : 86 - 92
  • [24] Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer
    Davison, B. Joyce
    Goldenberg, S. Larry
    BJU INTERNATIONAL, 2011, 108 (11) : 1787 - 1793
  • [25] Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer
    Van Hemelrijck, Mieke
    Garmo, Hans
    Lindhagen, Lars
    Bratt, Ola
    Stattin, Par
    Adolfsson, Jan
    EUROPEAN UROLOGY, 2017, 72 (04) : 534 - 541
  • [26] Can systemic immune-inflammation index and hematologic parameters aid in decision-making for active surveillance or curative treatment in low-risk prostate cancer?
    Baylan, Burhan
    Ulusoy, Kemal
    Ekenci, Berk
    Kartal, Ibrahim Guven
    ASIAN JOURNAL OF SURGERY, 2024, 47 (03) : 1360 - 1365
  • [27] Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs
    Tomer, Anirudh
    Rizopoulos, Dimitris
    Nieboer, Daan
    Drost, Frank-Jan
    Roobol, Monique J.
    Steyerberg, Ewout W.
    MEDICAL DECISION MAKING, 2019, 39 (05) : 499 - 508
  • [28] PSA-based prostate cancer screening: the role of active surveillance and informed and shared decision making
    Venderbos, Lionne D. F.
    Roobol, Monique J.
    ASIAN JOURNAL OF ANDROLOGY, 2011, 13 (02) : 219 - 224
  • [29] Qualitative study on decision-making by prostate cancer physicians during active surveillance
    Loeb, Stacy
    Curnyn, Caitlin
    Fagerlin, Angela
    Braithwaite, Ronald Scott
    Schwartz, Mark D.
    Lepor, Herbert
    Carter, Herbert Ballentine
    Sedlander, Erica
    BJU INTERNATIONAL, 2017, 120 (01) : 32 - 39
  • [30] Social ecological influences on treatment decision-making in men diagnosed with low risk, localised prostate cancer
    McIntosh, Megan
    Opozda, Melissa J.
    Short, Camille E.
    Galvao, Daniel A.
    Tutino, Rebecca
    Diefenbach, Michael
    Ehdaie, Behfar
    Nelson, Christian
    EUROPEAN JOURNAL OF CANCER CARE, 2022, 31 (06)